Jump to content

Property:Funding

From CAMIH

This is a property of type Text.

Showing 20 pages using this property.
B
Supported by grants R00-CA218603, R25-CA203650, P50CA127003, R01CA205406, R01CA118553 from the National Cancer Institute of the National Institutes of Health, grant U54-GM104940 from the National Institute of General Medicine Sciences of the National Institutes of Health, and grant P30-DK072476 from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health; additional funding was provided by the Gloria Spivak Faculty Advancement Award, Friends of Dana-Farber Cancer Institute Award, Project P Fund, Douglas Gray Woodruff Chair fund, Consano, Pharmavite LLC, and Genentech; pharmavite provided the vitamin D3 and placebo capsules for the study The funders/sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation of the manuscript; and decision to submit the manuscript for publication. Pharmavite and Genentech reviewed and approved the manuscript.  +
C
Lyc-O-Mato ® was sponsored by Lyco-Red, Israel, and fish oil was sponsored by Dr. Howard Fine of Roche Vitamins, Parsippany, NJ.  +
National R&D Program for Cancer Control (No. 0820300), Ministry of Health and Welfare, Seoul, Republic of Korea.  +
This research was funded by the American Institute for Cancer Research, UAB Comprehensive Cancer Center, Nutrition Obesity Research Center P30DK56336, and Diabetes Research Center P60DK079626.  +
L-carnitine was a standardized commercial preparation of 10 g of levocarnitine inert salt in 100-mL solution, provided by Sigma Tau Pharmaceuticals, Gaithersburg, MD.  +
The authors received research grants from the Canadian Institutes of Health Research and the Fonds de recherche en santé du Québec. ICN Valeant Pharmaceuticals provided the nabilone and the placebo pills during the trial.  +
D
A grant from the Royal Marsden Hospital Charity Panel pro- vided the funding for the Data Manager who manages data for studies conducted by the Therapies Department (CP08201). There was no other funding for this study.  +